FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to oligosaccharide carrier conjugates effective for treating and preventing infectious diseases and containing an oligosaccharide conjugated with the carrier through a linker of formulas
VIIIa
or
VIIIb:
wherein n is more than 1, m is specified in 1-10, p is specified in 1-20 and R represents H or alkyl; the linker is bound to an oligosaccharide oxygen atom through a terminal CH2 group, and the linker is bound through a terminal CO group with an amino group of the carrier compound by an amide bond; the oligosaccharide is β-1-6 related glucosamine, and the carrier is peptide, protein, polysaccharide, nucleic acid, lipid or tetanus toxoid.
EFFECT: there are presented new conjugates effective to stimulate the immune response, and a method for preparing them.
21 cl, 12 ex, 23 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
POLYSACCHARIDE-PROTEIN CONJUGATE POLYSACCHARIDE-PROTEIN FOR INDUCING IMMUNE RESPONSE AND PROTECTION AGAINST Staphylococcus aureus INFECTION, METHODS OF CONJUGATE OBTAINING (VERSIONS), CONJUGATE-CONTAINING COMPOSITION AND METHODS OF INDUCING IMMUNE RESPONSE AND PREVENTION OF Staphylococcus aureus INFECTION | 2010 |
|
RU2531234C2 |
CONJUGATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR POLYSACCHARIDES | 2010 |
|
RU2603267C2 |
IMMUNOGENIC COMPOSITION APPLICABLE FOR STAPHYLOCOCCUS VACCINATION | 2009 |
|
RU2521501C2 |
IMMUNOGENIC CONJUGATE OF BETA-PROPIONAMIDE-BOUND POLYSACCHARIDE WITH PROTEIN APPLIED AS VACCINE | 1999 |
|
RU2249463C2 |
MOLECULE CONTAINING spr0096 AND spr2021 | 2012 |
|
RU2636350C2 |
IMMUNOGENIC COMPOSITION | 2005 |
|
RU2402347C2 |
IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS | 2010 |
|
RU2536981C9 |
PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES | 2010 |
|
RU2579900C2 |
BACTERIAL VACCINE AND METHODS FOR PRODUCTION THEREOF | 2014 |
|
RU2684615C2 |
VACCINATION WITH MENINGOCOCCAL COJUGATES | 2006 |
|
RU2429011C2 |
Authors
Dates
2014-11-20—Published
2009-07-21—Filed